| 000 | 01906cam a2200253 4500500 | ||
|---|---|---|---|
| 005 | 20250112062022.0 | ||
| 041 | _afre | ||
| 042 | _adc | ||
| 100 | 1 | 0 |
_aGrenier, Catherine _eauthor |
| 700 | 1 | 0 |
_a Le Guludec, Dominique _eauthor |
| 700 | 1 | 0 |
_a de Montalembert, Pierre _eauthor |
| 700 | 1 | 0 |
_a Mounic, Vincent _eauthor |
| 245 | 0 | 0 | _aThe Haute Autorité de Santé and the standardization of medicine |
| 260 | _c2020. | ||
| 500 | _a85 | ||
| 520 | _aThe health care sector, like many other sectors, is not immune to the standardization process. Unlike other sectors, however, it is characterized by hazard. It is subject to a permanent evolution of knowledge and diagnostic and therapeutic means. This is the basis for the concept of evidence-based medicine (EBM): basing clinical decisions on the best evidence.Falling within this context is the work of the Haute Autorité de santé (HAS) (French National Authority for Health), an independent public body of a scientific nature, with broad missions. The HAS evaluates drugs, medical devices, and procedures; evaluates and recommends good professional practice and draws up public health recommendations; and measures and improves quality in health, social, and medical-social institutions.HAS’s missions mean that it is fully involved in the standardization process, but in a unique way. It achieves this by respecting a few key principles: the participation of the professionals and representatives of the patients and users concerned, transparency, independence, and the management of conflicts of interest. | ||
| 690 | _aquality and safety of care | ||
| 690 | _astandards | ||
| 690 | _agood practice recommendations | ||
| 690 | _aEBM | ||
| 690 | _aHAS | ||
| 786 | 0 | _nLes Tribunes de la santé | o 64 | 2 | 2020-06-19 | p. 37-47 | 1765-8888 | |
| 856 | 4 | 1 | _uhttps://shs.cairn.info/journal-les-tribunes-de-la-sante-2020-2-page-37?lang=en |
| 999 |
_c229112 _d229112 |
||